🔥 🔥 Our 20th anniversary EuroPCR edition OUT TODAY with: 📌 State-of-the-Art on the treatment of PFO; 📌 Expert review of leaflet modification techniques during TAVI; 📌 Long-term structural valve deterioration after TAVI; 📌 Ticagrelor monotherapy; 📌

🔥#EuroPCR 2025 Major Late-Breaking Trials: Meta-Analysis of Individual Patient Data from the PROTECTED #TAVR and BHF PROTECT-TAVI Trials Despite a clear rationale leading to the development of CEP, this meta-analysis of individual data from these two large RCTs clearly

#EuroPCR2025 A prospective study evaluating next-day and 48-hour discharge after alternative access #TAVI (subclavian/axillary, carotid, transapical) found no increase in 30-day readmission or mortality across discharge strategies. Rodrigo Bagur 🇦🇷🇨🇦 #EAPCI

Outstanding presentation by friend Pablo Lamelas 🇦🇷🇨🇦 at @EuroPCR 2025 on revascularization strategies for left main disease for LATAM and simultaneous publication internationaljournalofcardiology.com/article/S0167-… Oscar Mendiz Mamas A. Mamas

Congratulations Pablo Lamelas 🇦🇷🇨🇦 for leading on this important work/ guidelines It was a pleasure to work with LATAM cardiol and surgeons to produce this impactful guidance

Just published in The Lancet Neurology and presented at #ESOC2025 The DAYLIGHT RCT showing improved detection of cardiac thrombi without delay in IVT by extended CT angiography including the heart. Great effort by Luciano Sposato 🇦🇷🇨🇦 & Rodrigo Bagur 🇦🇷🇨🇦 and team 👏👏👏 sciencedirect.com/science/articl…

What if I told you it is possible to increase 6⃣ times the detection of cardioaortic thrombi in stroke patients with a simple tweak to your current workflow? 🤯🤯🤯 We would only need to screen 1⃣4⃣ patients to find 1⃣ thrombus! Curious? Read on! DAYLIGHT Trial

Tremendous work lead by THE ONE and THE ONLY Luciano Sposato 🇦🇷🇨🇦 thx letting me be part of your team

Upon the occasion of #EuroPCR, the PCRonline Editorial Board, led by Editor-in-Chief Salvatore Brugaletta and the Journal Club team, led by Journal Club Chair Nicola Ryan, could meet up in person, exchange ideas and discuss content strategy. We are so grateful 🙏 to each and every

A clinical trial led by LHSCRI and Western University’s Schulich WesternU has helped improve the detection of hidden blood clots. See how this could enhance stroke treatment: lhscri.ca/news/clinical-…

‘A very simple idea’ might make a big difference for stroke patients ctvnews.ca/london/article…

I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked 16th out of 230 journals in the cardiovascular category (+5 positions versus the previous year). Thank you all — it’s an exciting rollercoaster.

Next-day discharge after alternative access #TAVI? In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2. Rodrigo Bagur 🇦🇷🇨🇦

“Papá, we have AC/DC tomatoes” well son, will have to find the other half 😂

of course! PPM matter!

It was last night when Black Sabbath made a final show like no other, BACK TO THE BEGINNING. A thread🧵for those who missed some incredible live performances & highlights. 1- Steven Tyler, 77 years old, kicked the hell of a Whole Lotta Love performance by Led Zeppelin.

📖 A new study demonstrates that frailty is common amongst patients receiving Impella mechanical circulatory support #MCS and is associated with higher rates of readmission and adverse outcomes during readmission. Read more ⬇️ cjcopen.ca/article/S2589-… Mamas A. Mamas Abdulla A. Damluji, MD, PhD

How do you decide the optimal antiplatelet duration in cancer patients post AMI? we published the PRECISE-DAPT cancer score a few months ago: academic.oup.com/eurheartj/arti… today we publish the validation in the international BLEEMACS registry with Mo Daf Francesco Costa Evan Kontopantelis

13yrs post Absorb BVS 😊 ⁦Gregg W. Stone MD⁩ ⁦Abbott⁩

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT | JACC: Advances jacc.org/doi/10.1016/j.…